STOCK TITAN

[Form 4] NeueHealth, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

NEA 15 GP, LLC filed a Form 4 reporting multiple transactions in NeueHealth, Inc. (NEUE) on 10/02/2025 with the filing signed on 10/06/2025. The reporting person is the sole general partner of a chain of entities that indirectly held the shares and disclaims direct beneficial ownership where no pecuniary interest exists. The filing shows a mix of warrant exercises and cashless net exercises that initially increased exercisable common shares and underlying warrants, followed by contributions and cancellations tied to a merger.

Specifically, warrants exercisable at $0.01 were exercised or became exercisable for 189,195 and 434,297 shares; a cashless net exercise resulted in surrender of 280 shares and a separate surrender of 643 shares based on a market price of $6.75. Under rollover agreements implemented as part of the merger effective 10/02/2025, reported shareholdings were contributed to NH Holdings 2025 SPV, L.P. (Ultimate Parent) and the issuer's common shares were cancelled, leaving certain reported holdings at 0 shares following the merger.

NEA 15 GP, LLC ha presentato un Modulo 4 riportando molteplici operazioni su NeueHealth, Inc. (NEUE) il 10/02/2025 con la presentazione firmata il 10/06/2025. La persona che segnala è l'unico socio accomandatario di una catena di entità che indirettamente detenevano le azioni e nega la proprietà diretta benefica laddove non esista alcun interesse pecuniario. La denuncia mostra un mix di esercizi di warrant ed esercizi netti senza contanti che inizialmente hanno aumentato le azioni comuni esercitabili e i warrant sottostanti, seguiti da contributi e cancellazioni legate a una fusione.

Specifica, i warrant esercitabili a $0.01 sono stati esercitati o sono divenuti esercitabili per 189,195 azioni e 434,297 azioni; un esercizio netto in contanti ha comportato la consegna di 280 azioni e una separata consegna di 643 azioni basata su un prezzo di mercato di $6.75. Sulla base di accordi di rollover implementati nell'ambito della fusione efficace 10/02/2025, le partecipazioni riportate sono state conferite a NH Holdings 2025 SPV, L.P. (Ultimate Parent) e le azioni ordinarie dell'emittente sono state cancellate, lasciando alcune partecipazioni riportate a 0 azioni dopo la fusione.

NEA 15 GP, LLC presentó un Formulario 4 reportando múltiples transacciones en NeueHealth, Inc. (NEUE) el 10/02/2025 con la firma de la presentación el 10/06/2025. La persona que reporta es el único socio general de una cadena de entidades que poseían las acciones de forma indirecta y niega la propiedad beneficiosa directa cuando no existe interés pecuniario. La presentación muestra una mezcla de ejercicios de warrants y ejercicios netos sin efectivo que inicialmente aumentaron las acciones comunes ejercitables y los warrants subyacentes, seguidos de aportes y cancelaciones vinculadas a una fusión.

Específicamente, warrants ejercitables a $0.01 fueron ejercitados o se volvieron ejercitables para 189,195 y 434,297 acciones; un ejercicio neto sin efectivo resultó en la entrega de 280 acciones y una entrega separada de 643 acciones basada en un precio de mercado de $6.75. Bajo acuerdos de rollover implementados como parte de la fusión efectiva el 10/02/2025, las participaciones reportadas fueron aportadas a NH Holdings 2025 SPV, L.P. (Ultimate Parent) y las acciones comunes del emisor fueron canceladas, dejando determinadas participaciones reportadas en 0 acciones tras la fusión.

NEA 15 GP, LLCNeueHealth, Inc. (NEUE)에 대한 다수의 거래를 2025-10-02에 보고하는 Form 4를 제출했으며 서명은 2025-10-06에 이루어졌습니다. 보고자는 주식을 간접적으로 보유한 체인 구조의 유일한 일반 파트너이며 금전적 이해관계가 없을 경우 직접적 수익 지분을 부인합니다. 보고서는 매입가능한 워런트와 현금 없는 순익의 혼합으로 초기에는 행사 가능 일반주식과 기초 워런트를 증가시켰다가 합병과 관련된 납입 및 취소가 이어졌음을 보여줍니다.

특히 $0.01의 행사 가능 워런트가 189,195주와 434,297주로 행사되었거나 행사 가능해졌고, 현금없는 순익으로 280주를 양도하고 별도의 643주를 양도했습니다. 시장가격은 $6.75입니다. 합병의 일부로 시행된 롤오버 계약에 따라 보고된 주식 보유는 NH Holdings 2025 SPV, L.P. (Ultimate Parent)에 기여되었고 발행인의 보통주는 소멸되어 합병 후 보고된 일부 보유는 0주로 남게 되었습니다.

NEA 15 GP, LLC a déposé un Formulaire 4 signalant plusieurs transactions dans NeueHealth, Inc. (NEUE) le 10/02/2025 avec la signature du dépôt le 10/06/2025. La personne déclarant est le seul associé commanditaire d'une chaîne d'entités qui détenaient indirectement les actions et nie une propriété bénéficiaire directe lorsqu'il n'existe aucun intérêt pécuniaire. Le dépôt montre un mélange d'exercices de warrants et d'exercices nets sans argent qui ont d'abord augmenté les actions ordinaires exerçables et les warrants sous-jacents, puis des apports et des annulations liés à une fusion.

Plus précisément, les warrants exercissables à $0.01 ont été exercés ou sont devenus exerçables pour 189 195 et 434 297 actions; un exercice net en espèces a entraîné la cession de 280 actions et une cession distincte de 643 actions sur la base d'un prix de marché de $6.75. Dans le cadre des accords de rollover mis en place dans le cadre de la fusion effective le 10/02/2025, les participations déclarées ont été apportées à NH Holdings 2025 SPV, L.P. (Ultimate Parent) et les actions ordinaires de l'émetteur ont été annulées, laissant certaines participations déclarées à 0 actions après la fusion.

NEA 15 GP, LLC hat ein Formular 4 eingereicht, das mehrere Transaktionen in NeueHealth, Inc. (NEUE) am 10/02/2025 meldet, wobei die Einreichung am 10/06/2025 unterzeichnet wurde. Die meldepflichtige Person ist der einzige Generalpartner einer Kette von Rechtsträgern, die die Aktien indirekt hielten, und bestreitet eine direkte wirtschaftliche Eigentümerschaft, wenn kein wirtschaftliches Interesse besteht. Die Einreichung zeigt eine Mischung aus Warrants-Ausübungen und cashless Net Exercises, die zunächst die ausübbaren Stammaktien und die zugrunde liegenden Warrants erhöhten, gefolgt von Einlagen und Stornierungen im Zusammenhang mit einer Fusion.

Genauer gesagt wurden Warrants, die mit $0.01 ausübbar waren, für 189.195 und 434.297 Aktien ausgeübt oder ausübbar; ein bar-gleicher Nettobetrag veranlasste die Rückgabe von 280 Aktien und eine separate Rückgabe von 643 Aktien basierend auf einem Marktpreis von $6.75. Im Rahmen von Roll-Over-Vereinbarungen, die als Teil der Fusion mit Wirkung zum 10/02/2025 umgesetzt wurden, wurden die berichteten Anteile auf NH Holdings 2025 SPV, L.P. (Ultimate Parent) übertragen und die Stammaktien des Emittenten wurden storniert, sodass nach der Fusion bestimmte gemeldete Beteiligungen auf 0 Aktien reduziert wurden.

NEA 15 GP, LLC قدمت نموذج 4 يبلّغ عن عدة معاملات في NeueHealth, Inc. (NEUE) في 10/02/2025 مع توقيع الاعتماد في 10/06/2025. الشخص المبلغ عنه هو الشريك العام الوحيد لسلسلة من الكيانات التي امتلكت الأسهم بشكل غير مباشر وينفي الملكية المستفيدة المباشرة عندما لا يوجد أي مصلحة مالية. يحتوي الإبلاغ على مزيج من تمارين خيارات مرفقة وعمليات تمارين صافية بدون نقد زادت في البداية من الأسهم العادية القابلة للتمرين والخيارات الأساسية، تلتها مساهمات وإلغاءات مرتبطة باندماج.

على وجه التحديد، تم تمكين warrants قابلة للتمرين عند $0.01 وتم ممارستها أو أصبحت قابلة للممارسة لـ 189,195 و 434,297 سهماً؛ وكان تمرين صافي نقدي قد أسفر عن تسليم 280 سهماً وتسليم منفصل لـ 643 سهماً اعتماداً على سعر السوق $6.75. بموجب اتفاقات التدوير المطبقة كجزء من الاندماج الفعلي اعتباراً من 10/02/2025، تم الإسهام في الملكيات المعلنة إلى NH Holdings 2025 SPV, L.P. (Ultimate Parent) وتم إلغاء أسهم المصدر العادية، مما ترك بعض الحيازات المعلنة عند 0 سهمًا بعد الاندماج.

NEA 15 GP, LLC 提交了一份 Form 4,报告在 NeueHealth, Inc. (NEUE) 的多笔交易,日期为 2025/10/02,申报签署日期为 2025/10/06。报告人是一个系列实体的唯一普通合伙人,间接持有股份并在不存在任何经济利益时否认直接受益所有权。申报显示一开始以权证行使和无现金净行使的混合形式,导致可行使普通股和基础权证增加,随后出现与合并相关的认缴与取消。

具体而言,按 $0.01 可行使的权证被行使或成为可行使,共有 189,195 股和 434,297 股;一次无现金净行使导致放弃 280 股,另一次放弃 643 股,基于市场价格 $6.75。根据作为合并部分实施的滚存协议,报告的股权在合并生效日 2025/10/02 被转移至 NH Holdings 2025 SPV, L.P. (Ultimate Parent),发行人的普通股被取消,合并后某些报告的持股余额为 0 股。

Positive
  • Executed warrant exercises increased exercisable equity by 623,492 underlying shares before the merger
  • Cashless net exercise used a $6.75 reference price, avoiding a cash outlay for the reporting person
  • Rollover into Ultimate Parent preserved economic interests via limited partnership interests rather than outright sale
Negative
  • Cancellation of contributed common stock following the merger resulted in reported beneficial ownership of 0 shares for certain holdings
  • Large share movements (exercises and contributions totaling hundreds of thousands of shares) materially changed public share count held by the reporting entities
  • Indirect ownership structure and disclaimers mean public disclosure of precise pecuniary interests is limited

Insights

Insider reported exercises then converted equity into parent LP interests during a merger.

The reporting chain shows the reporting person as general partner of funds that held the shares indirectly, and it uses rollover agreements to exchange common stock for limited partnership interests in the Ultimate Parent on 10/02/2025. This preserves economic exposure while removing the issuer's public common shares from those holders.

Key dependencies include the terms of the rollover and any lockups or transfer restrictions within Ultimate Parent; monitor whether limited partnership interests carry the same economic and voting rights as cancelled public shares in the near term.

Warrant activity and a cashless net exercise altered share counts before a merger canceled public shares.

Warrants with a $0.01 exercise price were exercised for 189,195 and 434,297 shares; two cashless net exercises surrendered 280 and 643 shares using a reference price of $6.75. These actions increased exercisable underlying shares prior to the merger that contributed and then cancelled those shares.

Watch for any disclosed conversion mechanics or future issuance of equity by Ultimate Parent that could affect dilution or timing of liquidity for these holders; the filing identifies the warrants' expiration through 10/02/2030 for certain issuances.

NEA 15 GP, LLC ha presentato un Modulo 4 riportando molteplici operazioni su NeueHealth, Inc. (NEUE) il 10/02/2025 con la presentazione firmata il 10/06/2025. La persona che segnala è l'unico socio accomandatario di una catena di entità che indirettamente detenevano le azioni e nega la proprietà diretta benefica laddove non esista alcun interesse pecuniario. La denuncia mostra un mix di esercizi di warrant ed esercizi netti senza contanti che inizialmente hanno aumentato le azioni comuni esercitabili e i warrant sottostanti, seguiti da contributi e cancellazioni legate a una fusione.

Specifica, i warrant esercitabili a $0.01 sono stati esercitati o sono divenuti esercitabili per 189,195 azioni e 434,297 azioni; un esercizio netto in contanti ha comportato la consegna di 280 azioni e una separata consegna di 643 azioni basata su un prezzo di mercato di $6.75. Sulla base di accordi di rollover implementati nell'ambito della fusione efficace 10/02/2025, le partecipazioni riportate sono state conferite a NH Holdings 2025 SPV, L.P. (Ultimate Parent) e le azioni ordinarie dell'emittente sono state cancellate, lasciando alcune partecipazioni riportate a 0 azioni dopo la fusione.

NEA 15 GP, LLC presentó un Formulario 4 reportando múltiples transacciones en NeueHealth, Inc. (NEUE) el 10/02/2025 con la firma de la presentación el 10/06/2025. La persona que reporta es el único socio general de una cadena de entidades que poseían las acciones de forma indirecta y niega la propiedad beneficiosa directa cuando no existe interés pecuniario. La presentación muestra una mezcla de ejercicios de warrants y ejercicios netos sin efectivo que inicialmente aumentaron las acciones comunes ejercitables y los warrants subyacentes, seguidos de aportes y cancelaciones vinculadas a una fusión.

Específicamente, warrants ejercitables a $0.01 fueron ejercitados o se volvieron ejercitables para 189,195 y 434,297 acciones; un ejercicio neto sin efectivo resultó en la entrega de 280 acciones y una entrega separada de 643 acciones basada en un precio de mercado de $6.75. Bajo acuerdos de rollover implementados como parte de la fusión efectiva el 10/02/2025, las participaciones reportadas fueron aportadas a NH Holdings 2025 SPV, L.P. (Ultimate Parent) y las acciones comunes del emisor fueron canceladas, dejando determinadas participaciones reportadas en 0 acciones tras la fusión.

NEA 15 GP, LLCNeueHealth, Inc. (NEUE)에 대한 다수의 거래를 2025-10-02에 보고하는 Form 4를 제출했으며 서명은 2025-10-06에 이루어졌습니다. 보고자는 주식을 간접적으로 보유한 체인 구조의 유일한 일반 파트너이며 금전적 이해관계가 없을 경우 직접적 수익 지분을 부인합니다. 보고서는 매입가능한 워런트와 현금 없는 순익의 혼합으로 초기에는 행사 가능 일반주식과 기초 워런트를 증가시켰다가 합병과 관련된 납입 및 취소가 이어졌음을 보여줍니다.

특히 $0.01의 행사 가능 워런트가 189,195주와 434,297주로 행사되었거나 행사 가능해졌고, 현금없는 순익으로 280주를 양도하고 별도의 643주를 양도했습니다. 시장가격은 $6.75입니다. 합병의 일부로 시행된 롤오버 계약에 따라 보고된 주식 보유는 NH Holdings 2025 SPV, L.P. (Ultimate Parent)에 기여되었고 발행인의 보통주는 소멸되어 합병 후 보고된 일부 보유는 0주로 남게 되었습니다.

NEA 15 GP, LLC a déposé un Formulaire 4 signalant plusieurs transactions dans NeueHealth, Inc. (NEUE) le 10/02/2025 avec la signature du dépôt le 10/06/2025. La personne déclarant est le seul associé commanditaire d'une chaîne d'entités qui détenaient indirectement les actions et nie une propriété bénéficiaire directe lorsqu'il n'existe aucun intérêt pécuniaire. Le dépôt montre un mélange d'exercices de warrants et d'exercices nets sans argent qui ont d'abord augmenté les actions ordinaires exerçables et les warrants sous-jacents, puis des apports et des annulations liés à une fusion.

Plus précisément, les warrants exercissables à $0.01 ont été exercés ou sont devenus exerçables pour 189 195 et 434 297 actions; un exercice net en espèces a entraîné la cession de 280 actions et une cession distincte de 643 actions sur la base d'un prix de marché de $6.75. Dans le cadre des accords de rollover mis en place dans le cadre de la fusion effective le 10/02/2025, les participations déclarées ont été apportées à NH Holdings 2025 SPV, L.P. (Ultimate Parent) et les actions ordinaires de l'émetteur ont été annulées, laissant certaines participations déclarées à 0 actions après la fusion.

NEA 15 GP, LLC hat ein Formular 4 eingereicht, das mehrere Transaktionen in NeueHealth, Inc. (NEUE) am 10/02/2025 meldet, wobei die Einreichung am 10/06/2025 unterzeichnet wurde. Die meldepflichtige Person ist der einzige Generalpartner einer Kette von Rechtsträgern, die die Aktien indirekt hielten, und bestreitet eine direkte wirtschaftliche Eigentümerschaft, wenn kein wirtschaftliches Interesse besteht. Die Einreichung zeigt eine Mischung aus Warrants-Ausübungen und cashless Net Exercises, die zunächst die ausübbaren Stammaktien und die zugrunde liegenden Warrants erhöhten, gefolgt von Einlagen und Stornierungen im Zusammenhang mit einer Fusion.

Genauer gesagt wurden Warrants, die mit $0.01 ausübbar waren, für 189.195 und 434.297 Aktien ausgeübt oder ausübbar; ein bar-gleicher Nettobetrag veranlasste die Rückgabe von 280 Aktien und eine separate Rückgabe von 643 Aktien basierend auf einem Marktpreis von $6.75. Im Rahmen von Roll-Over-Vereinbarungen, die als Teil der Fusion mit Wirkung zum 10/02/2025 umgesetzt wurden, wurden die berichteten Anteile auf NH Holdings 2025 SPV, L.P. (Ultimate Parent) übertragen und die Stammaktien des Emittenten wurden storniert, sodass nach der Fusion bestimmte gemeldete Beteiligungen auf 0 Aktien reduziert wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
NEA 15 GP, LLC

(Last) (First) (Middle)
1954 GREENSPRING DRIVE
SUITE 600

(Street)
TIMONIUM MD 21093

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NeueHealth, Inc. [ NEUE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 X 189,195 A $0.01 1,527,217 I See Note 1(1)
Common Stock 10/02/2025 S(2) 280 D $6.75 1,526,937 I See Note 1(1)
Common Stock 10/02/2025 M 434,297 A $0.01 1,961,234 I See Note 1(1)
Common Stock 10/02/2025 F(2) 643 D $6.75 1,960,591 I See Note 1(1)
Common Stock 10/02/2025 D 1,960,591 D (3) 0 I See Note 1(1)
Common Stock 10/02/2025 D 43,678 D (3) 0 I See Note 4(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Buy) $0.01 10/02/2025 X 189,195 (5) (5) Common Stock 189,195 $0 0 I See Note 1(1)
Warrant (Right to Buy) $0.01 10/02/2025 A 434,297 10/02/2025 10/02/2030 Common Stock 434,297 (6) 434,297 I See Note 1(1)
Warrant (Right to Buy) $0.01 10/02/2025 M 434,297 (7) (7) Common Stock 434,297 $0 0 I See Note 1(1)
Explanation of Responses:
1. The Reporting Person is the sole general partner of NEA Partners 15, L.P. ("NEA Partners 15"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. ("NEA 15"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest.
2. Represents the cashless net exercise of a warrant through the surrender of shares to the Issuer based on a fair market value of $6.75 per share, the closing market price of the Issuer's common stock on October 1, 2025.
3. Pursuant to the Agreement and Plan of Merger, dated as of December 23, 2024, by and among the Issuer, NH Holdings 2025, Inc. ("Parent") and NH Holdings Acquisition 2025, Inc. ("Merger Sub"), on October 2, 2025, Merger Sub merged with and into the Issuer with the Issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to rollover agreements entered into between certain of the Reporting Persons and NH Holdings 2025 SPV, L.P. ("Ultimate Parent"), Parent and Merger Sub, each share of the Issuer's Common Stock beneficially owned by the Reporting Persons was contributed to Ultimate Parent in exchange for limited partnership interests in Ultimate Parent. Each such share of the Issuer's Common Stock was then cancelled and ceased to exist.
4. The Reporting Person is the sole general partner of NEA Partners 15-OF, L.P. ("NEA Partners 15-OF"). NEA Partners 15-OF is the sole general partner of NEA 15 Opportunity Fund, L.P. ("NEA 15-OF"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15-OF in which the Reporting Person has no pecuniary interest.
5. The warrants became exercisable as to 123,729 shares on April 30, 2024, 1,733 shares on June 21, 2024, 61,865 shares on October 2, 2024 and 1,868 shares on September 26, 2025.
6. Warrants issued pursuant to the Warrantholders Agreement, dated September 30, 2025 between the Issuer and the holders listed on Schedule 1 thereto, and the Credit Agreement, dated August 4, 2023, as amended by that certain Incremental Amendment No. 1, dated as of October 2, 2023, that certain Incremental Amendment No. 2, dated as of April 8, 2024, that certain Amendment No. 3, dated as of June 21, 2024, that certain Amendment No. 4, dated as of October 29, 2024, and that certain Amendment No. 5, dated as of September 30, 2025, between the Issuer and the lenders thereto.
7. The warrants became fully exercisable on October 2, 2025.
/s/ Zachary Bambach, attorney-in-fact 10/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did NEA 15 GP, LLC report on Form 4 for NEUE?

The filing reports warrant exercises, cashless net exercises and contributions of common stock into the Ultimate Parent on 10/02/2025, including exercises covering 189,195 and 434,297 shares and cashless surrenders of 280 and 643 shares.

How did the cashless net exercise work and what price was used?

The cashless net exercise surrendered shares to the issuer based on a closing market price of $6.75 per share as of 10/01/2025.

What happened to the contributed common stock after the transactions?

Per rollover agreements tied to the merger effective 10/02/2025, contributed common stock was exchanged for limited partnership interests in the Ultimate Parent and the underlying issuer shares were cancelled.

Does NEA 15 GP, LLC claim direct beneficial ownership of the reported shares?

The reporting person disclaims beneficial ownership of portions of the securities held by the funds where it has no pecuniary interest and reports indirect ownership through its role as sole general partner.

Are any warrants still outstanding after these transactions?

The filing notes certain warrants issued per a September 30, 2025 agreement and a warrant tranche that expires on 10/02/2030; some warrants became fully exercisable on 10/02/2025.
NeueHealth Inc

NYSE:NEUE

NEUE Rankings

NEUE Latest News

NEUE Latest SEC Filings

NEUE Stock Data

60.94M
7.28M
9.45%
58.37%
0.14%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
DORAL